At this hour, posts about Green Cross are surging on portal sites and stock market communities. As of today, foreign investors have made a net purchase of 51,016 shares of Green Cross, while institutional investors have made a net sale of 5,000 shares, according to provisional data. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.


As of 11:30 a.m. on October 22, 2020, Green Cross shares are trading at 237,500 KRW, up 8.2% from the previous day. The trading volume stands at 671,695 shares, which is 313.03% of the five-day average trading volume. On October 14, Green Cross became a market topic, being described as entering a phase of structural earnings growth driven by flu vaccines and Hunterase.


In addition to Green Cross, posts about Moatech (033200), Heungkuk Fire & Marine Insurance Preferred (000545), and Philosys Healthcare (057880) are also rapidly increasing among investors.



※ Source: AI investment assistant AI Rassiro


※ This article was automatically generated in real time by a news creation algorithm jointly developed by Asia Economy and ThinkPool, a financial AI company.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing